Belda-Iniesta C - Search Results

1

EPO-R expression patterns in resected gastric adenocarcinoma followed by adjuvant chemoradiation treatment.

Sereno M, De Castro J, Belda-Iniesta C, Garcia-Cabezas MA, Cejas P, Casado E, Barriuso J, Feliu J, Larrauri J. Sereno M, et al. Pathol Oncol Res. 2009 Mar;15(1):1-10. doi: 10.1007/s12253-008-9118-9. Epub 2008 Nov 11. Pathol Oncol Res. 2009. PMID: 19002606 Free article.

2

Immunohistochemical expression of p53, Bcl-2, COX-2, C-erb-B2, EPO-R, beta-catenin, and E-cadherin in non tumoral gastric mucous membrane.

Sereno M, García-Cabezas MA, De Castro J, Cejas P, Saenz EC, Belda-Iniesta C, Feijoo JB, Larrauri J, Nistal M, Baron MG. Sereno M, et al. Eur J Histochem. 2006 Oct-Dec;50(4):285-92. Eur J Histochem. 2006. PMID: 17213037

3

ERCC1 and topoisomerase I expression in small cell lung cancer: prognostic and predictive implications.

Sereno M, Cejas P, Moreno V, Belda-Iniesta C, López R, Nistal M, Feliu J, De Castro Carpeño J. Sereno M, et al. Int J Oncol. 2012 Jun;40(6):2104-10. doi: 10.3892/ijo.2012.1378. Epub 2012 Feb 16. Int J Oncol. 2012. PMID: 22344449 Free article.

4

Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma.

Cejas P, García-Cabezas MA, Casado E, Belda-Iniesta C, De Castro J, Fresno JA, Sereno M, Barriuso J, Espinosa E, Zamora P, Feliu J, Redondo A, Hardisson DA, Renart J, González-Barón M. Cejas P, et al. Free Radic Res. 2007 Jun;41(6):681-7. doi: 10.1080/10715760701286167. Free Radic Res. 2007. PMID: 17516241

5

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy.

Moreno García V, Cejas P, Blanco Codesido M, Feliu Batlle J, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Sánchez JJ, Larrauri J, González-Barón M, Casado E. Moreno García V, et al. Int J Colorectal Dis. 2009 Jul;24(7):741-8. doi: 10.1007/s00384-009-0682-6. Epub 2009 Mar 4. Int J Colorectal Dis. 2009. PMID: 19259690

6

Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.

Ramírez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Tarón M, Ramírez de Molina V, Cejas P, Skrzypski M, Gallego-Ortega D, de Castro J, Casado E, García-Cabezas MA, Sánchez JJ, Nistal M, Rosell R, González-Barón M, Lacal JC. Ramírez de Molina A, et al. Lancet Oncol. 2007 Oct;8(10):889-97. doi: 10.1016/S1470-2045(07)70279-6. Lancet Oncol. 2007. PMID: 17851129

7

Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells.

Belda-Iniesta C, Perona R, Carpeño Jde C, Cejas P, Casado E, Manguan-García C, Ibanez de Caceres I, Sanchez-Perez I, Andreu FB, Ferreira JA, Aguilera A, de la Peña J, Perez-Sánchez E, Madero R, Feliu J, Sereno M, González-Barón M. Belda-Iniesta C, et al. Cancer Biol Ther. 2007 Oct;6(10):1600-5. doi: 10.4161/cbt.6.10.4726. Epub 2007 Jul 12. Cancer Biol Ther. 2007. PMID: 17938574 Free article.

8

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.

Cejas P, López-Gómez M, Aguayo C, Madero R, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Moreno García V, Larrauri J, López R, Casado E, Gonzalez-Barón M, Feliu J. Cejas P, et al. PLoS One. 2009 Dec 18;4(12):e8199. doi: 10.1371/journal.pone.0008199. PLoS One. 2009. PMID: 20020061 Free PMC article.

9

A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer.

Casado E, García VM, Sánchez JJ, Blanco M, Maurel J, Feliu J, Fernández-Martos C, de Castro J, Castelo B, Belda-Iniesta C, Sereno M, Sánchez-Llamas B, Burgos E, García-Cabezas MÁ, Manceñido N, Miquel R, García-Olmo D, González-Barón M, Cejas P. Casado E, et al. Clin Cancer Res. 2011 Jun 15;17(12):4145-54. doi: 10.1158/1078-0432.CCR-10-2257. Epub 2011 Apr 5. Clin Cancer Res. 2011. PMID: 21467161

10

Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.

Casado E, Garcia VM, Sánchez JJ, Gómez Del Pulgar MT, Feliu J, Maurel J, Castelo B, Moreno Rubio J, López RA, García-Cabezas MÁ, Burgos E, de Castro J, Belda-Iniesta C, López-Gómez M, Gómez-Raposo C, Zambrana F, Sereno M, Fernández-Martos C, Vázquez P, Lacal JC, González-Barón M, Cejas P. Casado E, et al. Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1151-8. doi: 10.1016/j.ijrobp.2012.01.083. Epub 2012 Apr 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22516806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters